The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
MECHANISMS OF ENDOCRINOLOGY: Endocrinology of opioids
Open accessAbstract
The use of opioids has grown substantially over the past two decades reaching the dimensions of a global epidemic. These drugs have effects on multiple levels of the endocrine system through mechanisms which are still not fully elucidated, and awareness of their endocrine sequelae is vital for all specialists prescribing or managing patients on them. Hypogonadism is the most well-recognised consequence of opioid use (prevalence 21–86%) which, however, may remain undiagnosed with potential adverse outcomes for the patients. Although less frequent, cortisol deficiency can also be found. Furthermore, there is a negative impact on bone health (with reduced bone mineral density and increased fracture risk) and occasionally hyperprolactinaemia, whereas the clinical significance of alterations in other hormones remains to be clarified. Discontinuation or reduction of the opioid and, in cases of chronic pain, consideration of alternative therapies for pain relief are potential management options. Hormonal replacement, especially when the above measures are not practically feasible, needs to be considered. Further studies are needed to clearly establish the prevalence of hormonal abnormalities with various regimes, doses and routes of opioids and to address reliably the long-term benefits and risks of hormonal treatment in patients on opioids. Until evidence-based, safe and cost-effective clinical guidelines become available, periodical assessment of the gonadal and adrenal function (particularly when relevant clinical manifestations are present) and evaluation of the bone health status are advised.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945
Self-citationBasic opioid pharmacology: an update
Pathan, H., & Williams, J. (2012) · British Journal of Pain · doi:10.1177/2049463712438493 · Cited by 671
Neuroendocrine Control of Growth Hormone Secretion
Müller, E. E., Locatelli, V., & Cocchi, D. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.2.511 · Cited by 634
The effects of opioids and opioid analogs on animal and human endocrine systems
Vuong, C., Van Uum, S. H. M., O'Dell, L. E., Lutfy, K., & Friedman, T. C. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0009 · Cited by 564
Endocrine consequences of long-term intrathecal administration of opioids
Abs, R., Verhelst, J., Maeyaert, J., Van Buyten, J.-P., Opsomer, F., Adriaensen, H., Verlooy, J., Van Havenbergh, T., Smet, M., & Van Acker, K. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.6.6615 · Cited by 491
Stein, C. (2016) · Annual Review of Medicine · doi:10.1146/annurev-med-062613-093100 · Cited by 480
Manchikanti, L. (2017) · Pain Physician · doi:10.36076/ppj.2017.s92 · Cited by 430
Hypogonadism in men consuming sustained-action oral opioids
Daniell, H. W. (2002) · The Journal of Pain · doi:10.1054/jpai.2002.126790 · Cited by 401
Prescription of long-acting opioids and mortality in patients with chronic noncancer pain
Ray, W. A., Chung, C. P., Murray, K. T., Hall, K., & Stein, C. M. (2016) · JAMA · doi:10.1001/jama.2016.7789 · Cited by 369
Gender differences in hypothalamic–pituitary–adrenal (HPA) axis reactivity
Uhart, M., Chong, R. Y., Oswald, L., Lin, P.-I., & Wand, G. S. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2006.02.003 · Cited by 274
Research works printed but not linked: 125
- 2013, Atrial natriuretic peptide, arginine vasopressin peptide and cortisol serum levels in opiate-dependent patients, Neuropsychobiology, 67, 111, 10.1159/000346110 · DOI · Paper page
- 2005, Bone mineral density in subjects using central nervous system-active medications, American Journal of Medicine, 118, 1414
- 2006, Open-label pilot study of testosterone patch therapy in men with opioid-induced androgen deficiency, Journal of Pain, 7, 200, 10.1016/j.jpain.2005.10.009 · DOI · Paper page
- 1974, Galactorrhea-amenorrhea syndrome associated with heroin addiction, American Journal of Obstetrics and Gynecology, 118, 966, 10.1016/0002-9378(74)90667-X · DOI · Paper page
- 2014, High-dose remifentanil suppresses stress response associated with pneumoperitoneum during laparoscopic colectomy, Journal of Anesthesia, 28, 334, 10.1007/s00540-013-1738-x · DOI
- 2003, Effects of systemic and epidural morphine on antidiuretic hormone levels in children, Paediatric Anaesthesia, 13, 508, 10.1046/j.1460-9592.2003.01096.x · DOI · Paper page
- 2006, The mu-opioid receptor polymorphism A118G predicts cortisol responses to naloxone and stress, Neuropsychopharmacology, 31, 204, 10.1038/sj.npp.1300856 · DOI
- 2015, Sex differences in acute hormonal and subjective response to naltrexone: the impact of menstrual cycle phase, Psychoneuroendocrinology, 52, 59, 10.1016/j.psyneuen.2014.10.013 · DOI
- 1996, Hypogonadism and methadone: hypothalamic hypogonadism after long-term use of high-dose methadone, Endocrine Practice, 2, 4, 10.4158/EP.2.1.4 · DOI
- 2015, Chronic spinal and oral morphine-induced neuroendocrine and metabolic changes in noncancer pain patients, Pain Medicine, 16, 715, 10.1111/pme.12661 · DOI · Paper page
- 2010, The effects of opioids and opioid analogs on animal and human endocrine systems, Endocrine Reviews, 31, 98, 10.1210/er.2009-0009 · DOI · Paper page
- 1984, Evidence that opiatergic and alpha-adrenergic mechanisms stimulate rat growth hormone release via growth hormone-releasing factor (GRF), Endocrinology, 114, 1950, 10.1210/endo-114-5-1950 · DOI · Paper page
- 2006, DHEAS deficiency during consumption of sustained-action prescribed opioids: evidence for opioid-induced inhibition of adrenal androgen production, Journal of Pain, 7, 901, 10.1016/j.jpain.2006.04.011 · DOI
- 1998, Opioid-receptor blockade blunts growth hormone (GH) secretion induced by GH-releasing hormone in the human male, Hormone and Metabolic Research, 30, 34, 10.1055/s-2007-978827 · DOI
- 2010, Changes in metabolic-related variables during chronic morphine treatment, Neurochemistry International, 57, 323, 10.1016/j.neuint.2010.06.011 · DOI
- 2016, Effect of the co-administration of glucose with morphine on glucoregulatory hormones and causing of diabetes mellitus in rats, Advanced Biomedical Research, 5, 21, 10.4103/2277-9175.175907 · DOI
- 2014, Changes in trends and pattern of strong opioid prescribing in primary care, European Journal of Pain, 18, 1343, 10.1002/j.1532-2149.2014.496.x · DOI · Paper page
- 1994, Multiple opiate receptor subtypes are involved in the stimulation of growth hormone release by beta-endorphin in female rats, Neuroendocrinology, 60, 69, 10.1159/000126721 · DOI
- 1985, Pituitary secretion of growth hormone in response to opioid peptides and opiates is mediated through growth hormone-releasing factor, Neuroendocrinology, 41, 13, 10.1159/000124147 · DOI · Paper page
- 1989, Morphine directly modulates the release of stimulated corticotrophin-releasing factor-41 from rat hypothalamus in vitro, Endocrinology, 124, 2330, 10.1210/endo-124-5-2330 · DOI
- 1986, Different opioid mechanisms are involved in the modulation of ACTH and gonadotrophin release in man, Neuroendocrinology, 42, 357, 10.1159/000124463 · DOI
- 2008, Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain, Journal of Pain, 9, 28, 10.1016/j.jpain.2007.08.005 · DOI · Paper page
- 2016, Adrenal insufficiency in patients on long-term opioid analgesia, Clinical Endocrinology, 85, 831, 10.1111/cen.13125 · DOI · Paper page
- 2005, Enhanced prolactin levels in opium smokers, Addiction Biology, 10, 345, 10.1080/13556210500351263 · DOI · Paper page
- 1979, Effects of heroin addiction on thyrotrophin, thyroid hormones and porlactin secretion in men, Clinical Endocrinology, 10, 557, 10.1111/j.1365-2265.1979.tb02115.x · DOI
- 1984, Impaired circadian rhythmicity of beta-lipotrophin, beta-endorphin and ACTH in heroin addicts, Acta Endocrinologica, 105, 149, 10.1530/acta.0.1050149 · DOI · Paper page
- 2002, Sex hormone suppression by intrathecal opioids: a prospective study, Clinical Journal of Pain, 18, 144, 10.1097/00002508-200205000-00002 · DOI
- 2007, Secondary adrenal failure and secondary amenorrhoea following hydromorphone treatment, Clinical Endocrinology, 66, 604, 10.1111/j.1365-2265.2007.02779.x · DOI · Paper page
- 1987, Sex-related naloxone influence on growth hormone-releasing hormone-induced growth hormone secretion in normal subjects, Metabolism: Clinical and Experimental, 36, 105, 10.1016/0026-0495(87)90001-1 · DOI
- 1985, Effects of dopamine receptor stimulation on opiate-induced modifications of pituitary-gonadal function, Hormone Research, 21, 155, 10.1159/000180040 · DOI · Paper page
- 2013, Mu-opioid receptor A118G polymorphism in healthy volunteers affects hypothalamic-pituitary-adrenal axis adrenocorticotropic hormone stress response to metyrapone, Addiction Biology, 18, 325, 10.1111/j.1369-1600.2011.00313.x · DOI
- 1980, Effects of chronic heroin addiction on pituitary-thyroid function in man, Journal of Endocrinological Investigation, 3, 251, 10.1007/BF03348271 · DOI · Paper page
- 2015, Opioid partial agonist buprenorphine dampens responses to psychosocial stress in humans, Psychoneuroendocrinology, 52, 281, 10.1016/j.psyneuen.2014.12.004 · DOI
- 2011, Opioid analgesics suppress male gonadal function but opioid use in males and females does not correlate with symptoms of sexual dysfunction, Pain Research and Management, 16, 311, 10.1155/2011/807123 · DOI · Paper page
- 2012, Basic opioid pharmacology: an update, British Journal of Pain, 6, 11, 10.1177/2049463712438493 · DOI · Paper page
- 1987, Effects of fentanyl on vasopressin secretion in human subjects, Journal of Pharmacology and Experimental Therapeutics, 242, 970, 10.1016/S0022-3565(25)39200-1 · DOI · Paper page
- 2006, Fracture risk associated with the use of morphine and opiates, Journal of Internal Medicine, 260, 76, 10.1111/j.1365-2796.2006.01667.x · DOI · Paper page
- 2015, Opioid receptors, BJA Education, 15, 219, 10.1093/bjaceaccp/mku041 · DOI
- 1975, Effects of morphine on serum growth hormone, cortisol, prolactin and thyroid stimulating hormone in man, Journal of Clinical Endocrinology and Metabolism, 41, 797, 10.1210/jcem-41-4-797 · DOI · Paper page
- 1975, Function of the male sex organs in heroin and methadone users, New England Journal of Medicine, 292, 882, 10.1056/NEJM197504242921703 · DOI · Paper page
- 1994, Altered sexual function and decreased testosterone in patients receiving intraspinal opioids, Journal of Pain and Symptom Management, 9, 126, 10.1016/0885-3924(94)90166-X · DOI
- 2005, Chronic fentanyl application induces adrenocortical insufficiency, Journal of Internal Medicine, 257, 478, 10.1111/j.1365-2796.2005.01483.x · DOI · Paper page
- 2015, Effects of testosterone replacement in men with opioid-induced androgen deficiency: a randomized controlled trial, Pain, 156, 280, 10.1097/01.j.pain.0000460308.86819.aa · DOI · Paper page
- 2016, Effects of testosterone replacement on metabolic and inflammatory markers in men with opioid-induced androgen deficiency, Clinical Endocrinology, 85, 232, 10.1111/cen.13049 · DOI · Paper page
- 1975, Plasma testosterone levels in heroin addiction and during methadone maintenance, Journal of Pharmacology and Experimental Therapeutics, 192, 211, 10.1016/S0022-3565(25)30047-9 · DOI
- 2012, The impact of diacetylmorphine on hypothalamic-pituitary-adrenal axis activity and heroin craving in heroin dependence, European Addiction Research, 18, 116, 10.1159/000334411 · DOI
- 1993, Effects of chronic heroin abuse on bone and mineral metabolism, Acta Endocrinologica, 129, 42, 10.1530/acta.0.1290042 · DOI
- 1984, Differences in hypothalamo-pituitary-adrenocortical activity in the rat after acute and prolonged treatment with morphine, Neuroendocrinology, 38, 411, 10.1159/000123927 · DOI · Paper page
- 2015, Opioid-induced secondary adrenal insufficiency presenting as hypercalcaemia, Endocrinology Diabetes and Metabolism Case Reports, 2015, 150035
- 1982, A new Met-enkephalin analogue suppresses plasma vasopressin in man, Peptides, 3, 199, 10.1016/0196-9781(82)90051-1 · DOI
- 2006, Gender differences in hypothalamic-pituitary-adrenal (HPA) axis reactivity, Psychoneuroendocrinology, 31, 642, 10.1016/j.psyneuen.2006.02.003 · DOI · Paper page
- 2013, Hypogonadism and low bone mineral density in patients on long-term intrathecal opioid delivery therapy, BMJ Open, 3, e002856, 10.1136/bmjopen-2013-002856 · DOI · Paper page
- 2014, Elucidating risk factors for androgen deficiency associated with daily opioid use, American Journal of Medicine, 127, 1195, 10.1016/j.amjmed.2014.07.015 · DOI · Paper page
- 2009, Oral opioids for chronic non-cancer pain: higher prevalence of hypogonadism in men than in women, Experimental and Clinical Endocrinology and Diabetes, 117, 38
- 2003, Patients with chronic pain and abnormal pituitary function require investigation, Lancet, 361, 2203, 10.1016/S0140-6736(03)13775-0 · DOI · Paper page
- 2011, Hormone replacement therapy in morphine-induced hypogonadic male chronic pain patients, Reproductive Biology and Endocrinology, 9, 26, 10.1186/1477-7827-9-26 · DOI · Paper page
- 1982, The roles of opioid peptides in controlling thyroid stimulating hormone release, Life Sciences, 31, 2529, 10.1016/0024-3205(82)90760-3 · DOI
- 2012, Naltrexone effects on cortisol secretion in women and men in relation to a family history of alcoholism: studies from the Oklahoma Family Health Patterns Project, Psychoneuroendocrinology, 37, 1922, 10.1016/j.psyneuen.2012.04.006 · DOI
- 2014, Adrenal insufficiency in acute oral opiate therapy, Endocrinology Diabetes and Metabolism Case Reports, 2014, 130071
- 2004, Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids, Cancer, 100, 851, 10.1002/cncr.20028 · DOI · Paper page
- 2004, Opioid osteoporosis, Archives of Internal Medicine, 164, 338
- 1986, Alteration of pulsatile growth hormone secretion by growth-inducing exercise: involvement of endogenous opiates and somatostatin, Endocrinology, 118, 844, 10.1210/endo-118-2-844 · DOI
- 1989, Diurnal hormone variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis, Journal of Rheumatology, 19, 154
- 1988, Involvement of the hypothalamus in opiate-stimulated prolactin secretion, Regulatory Peptides, 20, 305, 10.1016/0167-0115(88)90065-1 · DOI
- consequences of opioid therapy Supplement https org, Psychoneuroendocrinology, 1
- 1996, Influence of acute and chronic morphine or stadol on the secretion of adrenocorticotrophin and its hypothalamic releasing hormone in the rat, Life Sciences, 59, 1881, 10.1016/S0024-3205(96)00535-8 · DOI
- 1975, Mechanism of action of narcotics in the production of menstrual dysfunction in women, Fertility and Sterility, 26, 538, 10.1016/S0015-0282(16)41173-8 · DOI
- 1991, Effects of morphine on the pituitary-thyroid axis: morphological and analytical studies, Functional and Developmental Morphology, 1, 3
- 2016, Prescription of long-acting opioids and mortality in patients with chronic noncancer pain, JAMA, 315, 2415, 10.1001/jama.2016.7789 · DOI · Paper page
- 1986, Effects of a kappa-opioid agonist on adrenocorticotropic and diuretic function in man, Hormone and Metabolic Research, 18, 842, 10.1055/s-2007-1012453 · DOI
- 2016, Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline, Journal of Clinical Endocrinology and Metabolism, 101, 3888, 10.1210/jc.2016-2118 · DOI · Paper page
- 2005, Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence, Journal of Clinical Endocrinology and Metabolism, 90, 203, 10.1210/jc.2004-0929 · DOI · Paper page
- 2011, Decreased bone density in men on methadone maintenance therapy, Addiction, 106, 349, 10.1111/j.1360-0443.2010.03159.x · DOI · Paper page
- 2016, Opioid receptors, Annual Review of Medicine, 67, 433, 10.1146/annurev-med-062613-093100 · DOI · Paper page
- 2015, Low-dose hydrocortisone replacement improves wellbeing and pain tolerance in chronic pain patients with opioid-induced hypocortisolemic responses. A pilot randomized, placebo-controlled trial, Psychoneuroendocrinology, 56, 157, 10.1016/j.psyneuen.2015.03.015 · DOI · Paper page
- 2015, Testosterone suppression in opioid users: a systematic review and meta-analysis, Drug and Alcohol Dependence, 149, 1, 10.1016/j.drugalcdep.2015.01.038 · DOI · Paper page
- 1988, Gonadal function in male heroin and methadone addicts, International Journal of Andrology, 11, 93, 10.1111/j.1365-2605.1988.tb00984.x · DOI · Paper page
- 2000, Opiate withdrawal in the neonatal rat: relationship to duration of treatment and naloxone dose, Psychopharmacology, 150, 253, 10.1007/s002130000413 · DOI
- 1985, Morphine inhibits the pituitary-adrenal response to ovine corticotropin-releasing hormone in normal subjects, Journal of Clinical Endocrinology and Metabolism, 60, 891, 10.1210/jcem-60-5-891 · DOI · Paper page
- 2011, Stimulatory effect of naloxone on plasma cortisol in human: possible direct stimulatory action at the adrenal cortex, Regulatory Peptides, 166, 1, 10.1016/j.regpep.2010.08.008 · DOI
- 1989, Opioids stimulate growth hormone (GH) release in man independently of GH-releasing hormone, Journal of Clinical Endocrinology and Metabolism, 69, 356, 10.1210/jcem-69-2-356 · DOI · Paper page
- 1983, Endocrine effects of methadone in rats; acute effects in adults, European Journal of Pharmacology, 95, 231, 10.1016/0014-2999(83)90639-8 · DOI
- 2000, Influence of asimadoline, a new kappa-opioid receptor agonist, on tubular water absorption and vasopressin secretion in man, British Journal of Clinical Pharmacology, 50, 227, 10.1046/j.1365-2125.2000.00256.x · DOI · Paper page
- 1983, The participation of hypothalamic dopamine in morphine-induced prolactin release in man, Clinical Endocrinology, 19, 437, 10.1111/j.1365-2265.1983.tb00017.x · DOI
- 2002, Hypogonadism in men consuming sustained-action oral opioids, Journal of Pain, 3, 377, 10.1054/jpai.2002.126790 · DOI · Paper page
- 1976, Effects of acetylmethadol on plasma testosterone, Clinical Pharmacology and Therapeutics, 19, 371, 10.1002/cpt1976193371 · DOI · Paper page
- 1982, Effect of morphine on the hypothalamic-pituitary axis in postmenopausal women, Fertility and Sterility, 37, 389, 10.1016/S0015-0282(16)46101-7 · DOI
- 1992, Opiate modulation of growth hormone secretion is compromised during the steroid-induced luteinizing hormone surge, Neuroendocrinology, 55, 214, 10.1159/000126117 · DOI
- 1985, Morphine-induced TSH release in normal and hypothyroid subjects, Neuroendocrinology, 40, 303, 10.1159/000124091 · DOI · Paper page
- 2014, Chronic heroin dependence leading to adrenal insufficiency, Case Reports in Endocrinology, 2014, 461816
- 1987, Effect of oral morphine and naloxone on pituitary-adrenal response in man induced by human corticotropin-releasing hormone, Acta Endocrinologica, 114, 509, 10.1530/acta.0.1140509 · DOI
- 2005, Effect of opiates on growth hormone secretion in acromegaly, Hormone and Metabolic Research, 37, 425, 10.1055/s-2005-870230 · DOI · Paper page
- 2003, Hypogonadism and sexual dysfunction in male cancer survivors receiving chronic opioid therapy, Journal of Pain and Symptom Management, 26, 1055, 10.1016/S0885-3924(03)00331-2 · DOI
- 1991, Changes in growth hormone and luteinizing hormone following acute or chronic administration of an opioid agonist, FK33-824, in wethers, Journal of Animal Science, 69, 774, 10.2527/1991.692774x · DOI
- 2010, Acute HPA axis response to naltrexone differs in female vs. male smokers, Psychoneuroendocrinology, 35, 596, 10.1016/j.psyneuen.2009.09.016 · DOI · Paper page
- 1972, Growth hormone in narcotic addiction, Journal of Clinical Endocrinology and Metabolism, 35, 352, 10.1210/jcem-35-3-352 · DOI · Paper page
- 1985, Effect of naloxone on the hormone response to CRF in normal man, Endocrine Research, 11, 39, 10.3109/07435808509035423 · DOI
- 1993, Effects of chronic stimulation or antagonism of opiate receptors on GH secretion in male and female rats, Life Sciences, 52, 1443, 10.1016/0024-3205(93)90068-E · DOI
- 2010, Opioid endocrinopathy: a clinical problem in patients with chronic pain and long-term oral opioid treatment, Clinical Journal of Pain, 26, 374, 10.1097/AJP.0b013e3181d1059d · DOI · Paper page
- 1998, Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: implications for the treatment of alcoholism, Alcoholism, Clinical and Experimental Research, 22, 1430, 10.1111/j.1530-0277.1998.tb03931.x · DOI
- 1985, Hypothalamus-pituitary-adrenal axis of heroin addicts, Drug and Alcohol Dependence, 15, 361, 10.1016/0376-8716(85)90014-6 · DOI · Paper page
- 1984, Plasma testosterone and luteinizing hormone levels during levo-alpha-acetylmethadol maintenance and withdrawal, Clinical Pharmacology and Therapeutics, 35, 545, 10.1038/clpt.1984.75 · DOI
- 1996, The steroidogenic effects of beta-endorphin and joining peptide: a potential role in the modulation of adrenal androgen production, Journal of Endocrinology, 151, 301, 10.1677/joe.0.1510301 · DOI
- 1998, Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain, Journal of Rheumatology, 25, 1374
- 2013, Opioid use for noncancer pain and risk of fracture in adults: a nested case-control study using the general practice research database, American Journal of Epidemiology, 178, 559, 10.1093/aje/kwt013 · DOI
- 1988, Hormone secretion in methadone-dependent and abstinent patients, NIDA Research Monograph, 81, 216
- 2011, Tramadol-induced adrenal insufficiency, European Journal of Clinical Pharmacology, 67, 865, 10.1007/s00228-011-0992-9 · DOI
- consequences of opioid therapy Supplement https org, Psychoneuroendocrinology, 1
- 1996, mu-Opioid agonists stimulate growth hormone secretion in immature rats, Neuroendocrinology, 63, 489, 10.1159/000127077 · DOI
- 2011, Opioid receptor subtypes: fact or artifact?, British Journal of Anaesthesia, 107, 8, 10.1093/bja/aer115 · DOI
- 1993, Effects of morphine and naloxone on prolactin and growth hormone gene expression in the male rat pituitary gland, Journal of Neuroendocrinology, 5, 553, 10.1111/j.1365-2826.1993.tb00521.x · DOI
- 1985, Effect of postoperative extradural morphine on ADH secretion, British Journal of Anaesthesia, 57, 407, 10.1093/bja/57.4.407 · DOI
- 2004, Opioid osteoporosis, Archives of Internal Medicine, 164, 338
- 2013, Hypogonadism in men with chronic pain linked to the use of long-acting rather than short-acting opioids, Clinical Journal of Pain, 29, 840, 10.1097/AJP.0b013e31827c7b5d · DOI
- ASIPP, safe and effective prescription of opioids for chronic non - cancer pain of Interventional Pain Physicians guidelines, American Society Pain Physician
- 1986, Haemodynamic and plasma vasopressin responses during high-dose fentanyl or sufentanil anaesthesia, Canadian Anaesthetists Society Journal, 33, 475, 10.1007/BF03010974 · DOI · Paper page
- 2000, Endocrine consequences of long-term intrathecal administration of opioids, Journal of Clinical Endocrinology and Metabolism, 85, 2215, 10.1210/jcem.85.6.6615 · DOI · Paper page
- 1975, Plasma testosterone levels during chronic heroin use and protracted astinence. A study of Hong Kong addicts, Clinical Pharmacology and Therapeutics, 17, 529, 10.1002/cpt1975175529 · DOI · Paper page
- 1981, Opiate receptors modulate LHRH and SRIF release from mediobasal hypothalamic neurons, Neuroendocrinology, 32, 163, 10.1159/000123150 · DOI · Paper page
- 2017, Association between commonly prescribed opioids and androgen deficiency in men: a retrospective cohort analysis, Pain Medicine, 18, 637
- 2000, Hypogonadism in patients treated with intrathecal morphine, Clinical Journal of Pain, 16, 251, 10.1097/00002508-200009000-00011 · DOI · Paper page
- 2002, Fentanyl-associated syndrome of inappropriate antidiuretic hormone secretion, Pharmacotherapy, 22, 1188, 10.1592/phco.22.13.1188.33526 · DOI
- 1999, Neuroendocrine control of growth hormone secretion, Physiological Reviews, 79, 511, 10.1152/physrev.1999.79.2.511 · DOI · Paper page
- 2008, Erectile dysfunction in men receiving methadone and buprenorphine maintenance treatment, Journal of Sexual Medicine, 5, 684, 10.1111/j.1743-6109.2007.00702.x · DOI · Paper page
- 1996, Opioid receptor activation resets the hypothalamic clock generating growth hormone secretory bursts in the rat, Journal of Endocrinology, 148, 149, 10.1677/joe.0.1480149 · DOI
Cited by
Opioids and their endocrine effects: a systematic review and meta-analysis
de Vries, F., Bruin, M., Lobatto, D. J., Dekkers, O. M., Schoones, J. W., van Furth, W. R., Pereira, A. M., Karavitaki, N., Biermasz, N. R., & Zamanipoor Najafabadi, A. H. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz022 · Cited by 139
Self-citationOpioid-induced endocrinopathies
Fountas, A., Van Uum, S., & Karavitaki, N. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30254-2 · Cited by 77
Self-citationAlcohol and illicit drug use in people with diabetes
Pastor, A., Conn, J., MacIsaac, R. J., & Bonomo, Y. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30410-3 · Cited by 53
Opioids and pituitary function: expert opinion
Gadelha, M. R., Karavitaki, N., Fudin, J., Bettinger, J. J., Raff, H., & Ben-Shlomo, A. (2022) · Pituitary · doi:10.1007/s11102-021-01202-y · Cited by 27
Self-citationExogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement
Karavitaki, N., Bettinger, J. J., Biermasz, N., Christ-Crain, M., Gadelha, M. R., Inder, W. J., Tsourdi, E., Wakeman, S. E., & Zatelli, M. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae023 · Cited by 14
Self-citation
Metadata
- Authors
- Fountas, A., Chai, S. T., Kourkouti, C., & Karavitaki, N.
- Affiliations
- University Hospitals Birmingham NHS Foundation Trust (GB)
- Corresponding author
- Karavitaki, Niki
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-10
- Volume
- 179
- Issue
- 4
- Pages
- R183-R196
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2811034727
- Semantic Scholar
- 06575ef15ed01e4a53be5e32ea069819c0df4c99
- Cited by
- 60
- References
- 126
- Citations by year
- 2026: 5 · 2025: 1 · 2024: 6 · 2023: 6 · 2022: 11 · 2021: 13 · 2020: 9 · 2019: 9
- FWCI
- 1.41
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (publishedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- opioid use, hypogonadism, cortisol deficiency, bone mineral density, fracture risk, hyperprolactinemia, gonadal function, adrenal function, hormone replacement therapy, chronic pain, opioid epidemic
- MeSH terms
- Deprescriptions, Analgesics, Opioid, Bone Diseases, Metabolic, Fractures, Spontaneous, Humans, Hydrocortisone, Hyperprolactinemia, Hypogonadism, Opioid-Related Disorders, Risk Factors, Bone Density, Prevalence, Fractures, Bone, Chronic Pain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: MECHANISMS OF ENDOCRINOLOGY: Endocrinology of opioids. https://app.cochat.ai/papers/10.1530/eje-18-0270
- The paper
- Fountas, A., Chai, S. T., Kourkouti, C., & Karavitaki, N. (2018). MECHANISMS OF ENDOCRINOLOGY: Endocrinology of opioids. European Journal of Endocrinology. https://doi.org/10.1530/eje-18-0270
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.